Protecting Participants of Clinical Trials Conducted in the Intensive Care Unit
Tóm tắt
Research in the intensive care unit (ICU) raises a number of scientific and ethical challenges. Potential participants in critical care studies are likely to be considered particularly vulnerable—they may lack sufficient capacity to make informed decisions about trial participation, their health care proxies may lack legal authority to enroll them in research trials or may not know their true intent, and the life-threatening nature of the illness may make them or their surrogates more susceptible to therapeutic misconception. Because of this, critical care investigators must exercise extreme caution when designing and conducting studies in the ICU. In this article, we review the key literature addressing the various scientific and ethical issues raised by critical care research, including questions of equipoise and the selection of control groups, informed consent, therapeutic misconception, conflict of interest, and quality improvement projects. We also describe the current status of key policy or regulatory initiatives designed to address these issues, particularly in light of recent controversies involving critical care studies like the ARDSNet trial.
Từ khóa
Tài liệu tham khảo
Monagle JF, 2004, Health Care Ethics: critical Issues for 21st Century, 2
Veatch RM, 2005, Mt Sinai J Med, 72, 236
Levine RJ, 1988, Ethics and Regulation of Clinical Research
US National Bioethics Advisory Commission (NBAC). Assessing risks and potential benefits and evaluating vulnerability . In: Nbac, ed. Ethical and Policy Issues in Research Involving Human Participants. Washington, DC: US Government Printing Office; 2001:69-85. http://govinfo.library.unt.edu/nbac/human/overvol1.pdf. Accessed May 6, 2009.
Slutsky AS, 2000, Resp Res, 1, 73
NIH Program on Clinical Research Policy Analysis and Coordination (CRpac) Considering Usual Care in Clinical Trial Design: scientific and Ethical Issues. Meeting proceedings November14-15, 2005.http://oba/od/nih.gov/policy/policy_issues.html . Accessed August 23, 2009.
Thompson BT, Presentation at the 2005 meeting on Considering Usual Medical Care in Clinical Trial Design: Scientific and Ethical Issues
Eichacker P., 2003, Am J Resp Crit Care Med, 166, 1510
Nuremberg Military Tribunal. Trials of War Criminals before the Nuremberg Military Tribunals Under Control Council Law No10, vol 2. Washington, DC: US Government Printing Office; 1949:181-182.
Appelbaum PS, 1989, Informed Consent: Legal Theory and Clinical Practice
US Department of Health and Human Services., 2009, Title 45 Part 46 (45 CFR 46; Public Welfare) Subpart A: Federal Policy for the Protection of Human Subjects
Dunn LB, 2006, Am J Psychiatry, 163, 1232
UCSD Human Research Protections Program., 2009, Decision making capacity guidelines
Danis M., Emanuel E., Silverman H. Ethical considerations in managing critically ill patients. In: Parillo J, Dellinger RP, eds. Critical Care Medicine: principles of Diagnosis and Management in the Adult. 3rd ed. Philadelphia, PA: Mosby; 2001: 1509-1529.
2010, OHRP Response to AHRP re: Surrogate Consent to Research
US Department of Health and Human Services., 2009, Title 45 Part 46 (45 CFR 46; Public Welfare) Subpart D: Additional Protections for Children Involved as Subjects in Research
US Department of Health and Human Services., 2008, Guidance for Sponsors, Clinical Investigators and IRBs: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials
US Food and Drug Administration., 2009, 21 CFR 50.24: Exception from Informed Consent Requirements for Emergency Research
US Department of Health and Human Services., 2009, 45 CRF 46.101(j): To What Does This Policy Apply?
Secretary’s Advisory Committee on Human Research Protections (SACHRP)., 2009, Meeting Minutes, March 3 and 4, 2009
National Bioethics Advisory Commission., 2001, Ethical and Policy issues in International Research: Clinical Trials in Developing Countries
1992, Federal Register 13250-13259
US National Institutes of Health., 2009, Understanding Clinical Trials
Institute of Medicine., 2009, Conflict of Interest in Medical Research, Education and Practice
US Department of Health and Human Services., 2009, 42 CRF 50 Subpart F: Objectivity in Research
US Food and Drug Administration., 2009, 21 CRF 54: Financial Disclosure by Clinical Investigators
Moore v. Regents of the University of California, 793 P.2d 479 (Cal.1990).
Gelsinger v Trustees of the University of Pennsylvania. Phila Cnty Ct of CP filed September 18, 2000. Sherman, Silverstein, Kohl, Rose and Podelsky law offices. http://www.sskrplaw.com/ links/healthcare2.html. Accessed September 12, 2009.
Milstein A., 2009, Gelsinger Complaint; 2000
American Association of Medical Colleges (AAMC), 2009, Task Force on Financial Conflicts of Interest in Clinical Research. Protecting Patients, Preserving Integrity, Advancing Health: accelerating the Implementation of COI Policies in Human Subjects Research
US Department of Health and Human Services., 2009, Financial Relationships and Interests in Research Involving Human Subjects: guidance for Human Subject Protection; 2004
2009, Physicians Payments Sunshine Act of 2009. Senate Bill S.309
Hansen D., 2008, Am Med News
74 Federal Register 21610-21613; 2009.
N. Thakur., Special Assistant to the NIH Deputy Director for Extramural Research. Personal communication
Institute of Medicine., 2009, Beyond the HIPAA Privacy Rule: enhancing Privacy, Improving Health Through Research
US Department of Health and Human Services., 2009, News release: OHRP concludes case regarding Johns Hopkins University research on hospital infections; encourages continuance of work to reduce incidence of catheter-related infections; offers new guidance for future research; 2008
US Department of Health and Human Services., 2009, OHRP quality improvement activities frequently asked questions; 2008
Gawande A. A lifesaving checklist. New York Times. 2007; December 30:A8.
US Department of Health and Human Services., 2007, OHRP statement regarding the New York Times op-ed entitled ‘‘A lifesaving checklist’’
Holm MJ, Selvan M., Smith ML, et al. Quality improvement or research: defining and supervising QI at the University of Texas M.D. Anderson Cancer Center. In: Jennings B, Baily MA , Lynn J, eds. Health Care Quality Improvement: Ethical and Regulatory Issues. Garrison, NY: The Hastings Center; 2007:145-168.